Charles Percy

2.0k total citations
9 papers, 138 citations indexed

About

Charles Percy is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Charles Percy has authored 9 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Genetics and 1 paper in Molecular Biology. Recurrent topics in Charles Percy's work include Hemophilia Treatment and Research (6 papers), Platelet Disorders and Treatments (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Charles Percy is often cited by papers focused on Hemophilia Treatment and Research (6 papers), Platelet Disorders and Treatments (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Charles Percy collaborates with scholars based in United Kingdom, United States and Germany. Charles Percy's co-authors include Peter W. Collins, Judith E. Hall, Valerie B. O’Donnell, Michael Dockal, Rudolf Hartmann, Dheeraj Mehta, Friedrich Scheiflinger, Gillian Lowe, Georgina Hall and C. R. M. Hay and has published in prestigious journals such as British Journal of Haematology, Journal of Clinical Medicine and Haemophilia.

In The Last Decade

Charles Percy

6 papers receiving 136 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Percy United Kingdom	4	122	35	19	13	12	9	138
Michèle Gouault-Heilmann France	7	97 0.8×	41 1.2×	2 0.1×	3 0.2×	6 0.5×	9	117
S. Squire Canada	5	65 0.5×	10 0.3×	8 0.4×	1 0.1×	7 0.6×	8	87
Gregory Kurio United States	3	66 0.5×	74 2.1×	2 0.1×		8 0.7×	7	100
George Newman United States	4	86 0.7×	60 1.7×	1 0.1×	5 0.4×	1 0.1×	8	118
Erin Law Switzerland	1	113 0.9×	82 2.3×	2 0.1×	1 0.1×	3 0.3×	3	121
Louise de Swart Netherlands	6	128 1.0×	107 3.1×		5 0.4×	12 1.0×	9	138
A. Essaian Russia	3	67 0.5×	34 1.0×	1 0.1×	4 0.3×	2 0.2×	8	80
Carmen Vecchiarelli Argentina	4	29 0.2×	36 1.0×		21 1.6×	6 0.5×	4	102
Cécile Kerloëguen Switzerland	3	52 0.4×	16 0.5×		7 0.5×	2 0.2×	5	64
Mohammad Ali Hajebrahimi Iran	6	20 0.2×	17 0.5×			12 1.0×	7	73

Countries citing papers authored by Charles Percy

Since Specialization

Citations

This map shows the geographic impact of Charles Percy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Percy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Percy more than expected).

Fields of papers citing papers by Charles Percy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Percy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Percy. The network helps show where Charles Percy may publish in the future.

Co-authorship network of co-authors of Charles Percy

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Percy. A scholar is included among the top collaborators of Charles Percy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Percy. Charles Percy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Fratter, Carl, Will Lester, Charles Percy, et al.. (2025). The diagnostic utility of genetic testing in inherited thrombocytopenia: regional multicenter tertiary experience. Research and Practice in Thrombosis and Haemostasis. 9(3). 102869–102869.

Xiang, Hua, Ben Palmer, Pratima Chowdary, et al.. (2025). Emicizumab utilization, safety, and outcomes in people with severe hemophilia and no inhibitors: 3-year follow-up. A report from the UK Haemophilia Centre Doctors’ Organisation. Research and Practice in Thrombosis and Haemostasis. 9(6). 103164–103164.

Escobar, Miguel A., Maureane Hoffman, Giancarlo Castaman, et al.. (2024). Recombinant factor VIIa: new insights into the mechanism of action through product innovation. Research and Practice in Thrombosis and Haemostasis. 9(1). 102670–102670.

Miesbach, Wolfgang, Nicola Curry, Paul Knöbl, et al.. (2024). Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS. Therapeutic Advances in Hematology. 15. 1574178092–1574178092. 1 indexed citations

Kenet, Gili, Yeu‐Chin Chen, Gillian Lowe, et al.. (2021). Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study. Journal of Clinical Medicine. 10(24). 5959–5959. 16 indexed citations

Hart, Daniel P., Jayanthi Alamelu, Neha Bhatnagar, et al.. (2021). Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update. Haemophilia. 27(6). 932–937. 17 indexed citations

Percy, Charles, Rudolf Hartmann, Dheeraj Mehta, et al.. (2014). Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass. Blood Coagulation & Fibrinolysis. 26(4). 357–367. 26 indexed citations

Collins, Peter W. & Charles Percy. (2009). Advances in the understanding of acquired haemophilia A: implications for clinical practice. British Journal of Haematology. 148(2). 183–194. 76 indexed citations

Percy, Charles, et al.. (2009). Laboratory monitoring of Scott Syndrome. British Journal of Haematology. 149(6). 803–803. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact